Tag: Biotech
Madrigal Pharmaceuticals Stock: RS Rating Upgrade Analysis
Madrigal Pharmaceuticals (MDGL) stock received an upgrade on Wednesday, increasing its Relative Strength (RS) Rating from 74 to 90. The RS Rating, which ranges...
© USANews.net - Covering the Heartbeat of America